EU regulator reviews AstraZeneca shot and blood clot links
LONDON (AP) — The world awaited the results Thursday of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine is linked to blood clots reported in small numbers of recipients of the shot.
Concerns over the clotting led more than a dozen European countries to suspend use of the vaccine over the past week, even though the company and international health agencies said there was no indication the vaccine caused the clotting and recommended continuing inoculations.